Telomeres and Telomerase

From Discovery to Clinical Trials

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Telomeres are the ends of linear chromosomes. They cannot be fully replicated by standard polymerases and are maintained by the ribonucleoprotein telomerase. Telomeres and telomerase stand at a junction of critical processes underlying chromosome integrity, cancer, and aging, and their importance was recognized by the 2009 Nobel Prize in Physiology or Medicine to Elizabeth Blackburn, Jack Szostak, and Carol Greider. Where will the field go now? What are the prospects for antitelomerase agents as drugs? Nearly 30 years after Szostak and Blackburn's pioneering manuscript on telomere ends, the challenges of discovery remain.

Original languageEnglish (US)
Pages (from-to)1219-1223
Number of pages5
JournalChemistry and Biology
Volume16
Issue number12
DOIs
StatePublished - Dec 24 2009

Fingerprint

Telomerase
Telomere
Chromosomes
Clinical Trials
Ribonucleoproteins
Jacks
Physiology
Medicine
Nobel Prize
Manuscripts
Aging of materials
Pharmaceutical Preparations
Neoplasms

Keywords

  • CELLBIO
  • CHEMBIO

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Molecular Biology
  • Clinical Biochemistry
  • Molecular Medicine
  • Pharmacology

Cite this

Telomeres and Telomerase : From Discovery to Clinical Trials. / Corey, David R.

In: Chemistry and Biology, Vol. 16, No. 12, 24.12.2009, p. 1219-1223.

Research output: Contribution to journalArticle

@article{eaa80219557547da875aad1688246c0c,
title = "Telomeres and Telomerase: From Discovery to Clinical Trials",
abstract = "Telomeres are the ends of linear chromosomes. They cannot be fully replicated by standard polymerases and are maintained by the ribonucleoprotein telomerase. Telomeres and telomerase stand at a junction of critical processes underlying chromosome integrity, cancer, and aging, and their importance was recognized by the 2009 Nobel Prize in Physiology or Medicine to Elizabeth Blackburn, Jack Szostak, and Carol Greider. Where will the field go now? What are the prospects for antitelomerase agents as drugs? Nearly 30 years after Szostak and Blackburn's pioneering manuscript on telomere ends, the challenges of discovery remain.",
keywords = "CELLBIO, CHEMBIO",
author = "Corey, {David R.}",
year = "2009",
month = "12",
day = "24",
doi = "10.1016/j.chembiol.2009.12.001",
language = "English (US)",
volume = "16",
pages = "1219--1223",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Telomeres and Telomerase

T2 - From Discovery to Clinical Trials

AU - Corey, David R.

PY - 2009/12/24

Y1 - 2009/12/24

N2 - Telomeres are the ends of linear chromosomes. They cannot be fully replicated by standard polymerases and are maintained by the ribonucleoprotein telomerase. Telomeres and telomerase stand at a junction of critical processes underlying chromosome integrity, cancer, and aging, and their importance was recognized by the 2009 Nobel Prize in Physiology or Medicine to Elizabeth Blackburn, Jack Szostak, and Carol Greider. Where will the field go now? What are the prospects for antitelomerase agents as drugs? Nearly 30 years after Szostak and Blackburn's pioneering manuscript on telomere ends, the challenges of discovery remain.

AB - Telomeres are the ends of linear chromosomes. They cannot be fully replicated by standard polymerases and are maintained by the ribonucleoprotein telomerase. Telomeres and telomerase stand at a junction of critical processes underlying chromosome integrity, cancer, and aging, and their importance was recognized by the 2009 Nobel Prize in Physiology or Medicine to Elizabeth Blackburn, Jack Szostak, and Carol Greider. Where will the field go now? What are the prospects for antitelomerase agents as drugs? Nearly 30 years after Szostak and Blackburn's pioneering manuscript on telomere ends, the challenges of discovery remain.

KW - CELLBIO

KW - CHEMBIO

UR - http://www.scopus.com/inward/record.url?scp=73149092074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149092074&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2009.12.001

DO - 10.1016/j.chembiol.2009.12.001

M3 - Article

VL - 16

SP - 1219

EP - 1223

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 12

ER -